Published in Brain Res on October 12, 2006
The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank (2008) 4.13
Antidepressant actions of histone deacetylase inhibitors. J Neurosci (2009) 3.17
Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci (2010) 2.84
Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem (2011) 2.82
ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics (2014) 2.81
Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med (2010) 2.09
Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med (2013) 1.70
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry (2008) 1.64
Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol (2008) 1.62
Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex (2008) 1.61
AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry (2008) 1.60
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci (2012) 1.52
Post-mortem tissue biopsies obtained at minimally invasive autopsy: an RNA-quality analysis. PLoS One (2014) 1.51
Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank (2010) 1.46
Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry (2015) 1.40
Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease. Nucleic Acids Res (2008) 1.40
Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry (2010) 1.30
Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues. BMC Genomics (2008) 1.28
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology (2015) 1.21
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet (2009) 1.21
Expression of four housekeeping proteins in elderly patients with schizophrenia. J Neural Transm (Vienna) (2009) 1.18
Stability of endogenous reference genes in postmortem human brains for normalization of quantitative real-time PCR data: comprehensive evaluation using geNorm, NormFinder, and BestKeeper. Int J Legal Med (2012) 1.18
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement (2013) 1.15
RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays. Int J Legal Med (2011) 1.15
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr Res (2008) 1.14
An Australian Brain Bank: a critical investment with a high return! Cell Tissue Bank (2008) 1.13
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol (2009) 1.13
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol (2009) 1.12
Identifying targets for preventing epilepsy using systems biology. Neurosci Lett (2011) 1.07
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.07
Profiling of RNA degradation for estimation of post morterm interval. PLoS One (2013) 1.07
Brain lipid concentrations in bipolar disorder. J Psychiatr Res (2009) 1.06
Selection of candidate housekeeping genes for normalization in human postmortem brain samples. Int J Mol Sci (2011) 1.05
Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder. Neuropsychopharmacology (2007) 1.04
Genomic profiles of damage and protection in human intracerebral hemorrhage. J Cereb Blood Flow Metab (2008) 1.03
Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophr Bull (2012) 1.01
Psychiatric brain banking: three perspectives on current trends and future directions. Biol Psychiatry (2010) 1.00
Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? Am J Psychiatry (2009) 0.98
Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry (2011) 0.97
Postmortem cardiac tissue maintains gene expression profile even after late harvesting. BMC Genomics (2012) 0.95
Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra. Front Psychiatry (2012) 0.95
Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci U S A (2013) 0.94
Validation of adequate endogenous reference genes for the normalisation of qPCR gene expression data in human post mortem tissue. Int J Legal Med (2010) 0.93
Postmortem brain: an underutilized substrate for studying severe mental illness. Neuropsychopharmacology (2013) 0.91
N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. Neuropsychopharmacology (2013) 0.91
Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies. Am J Med Genet B Neuropsychiatr Genet (2013) 0.90
Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia. Mol Psychiatry (2014) 0.90
The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience. Int J Mol Sci (2009) 0.89
Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. Transl Psychiatry (2013) 0.89
Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. J Biol Chem (2011) 0.89
Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology (2015) 0.88
Identification of Biomarkers in Breast Cancer by Gene Expression Profiling Using Human Tissues. Genom Data (2014) 0.88
Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. J Biol Chem (2011) 0.88
Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects. J Affect Disord (2008) 0.88
NPY mRNA expression in the prefrontal cortex: Selective reduction in the superficial white matter of subjects with schizoaffective disorder. Schizophr Res (2009) 0.88
Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs. Mol Psychiatry (2013) 0.87
The GABAβ receptor as a target for antidepressant drug action. Br J Pharmacol (2011) 0.86
Stereological analysis of neuron, glial and endothelial cell numbers in the human amygdaloid complex. PLoS One (2012) 0.86
Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia. Neuropharmacology (2011) 0.84
A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype. Neuropsychopharmacology (2014) 0.84
Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis. Hippocampus (2013) 0.83
Regional differences in expression of β-tubulin isoforms in schizophrenia. Schizophr Res (2012) 0.83
High quality DNA obtained with an automated DNA extraction method with 70+ year old formalin-fixed celloidin-embedded (FFCE) blocks from the indiana medical history museum. Am J Transl Res (2012) 0.83
Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior. Eur Arch Psychiatry Clin Neurosci (2010) 0.83
Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response. Synapse (2011) 0.83
An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors. Mol Psychiatry (2013) 0.83
Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program. Cell Tissue Bank (2016) 0.83
Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease. Alzheimers Res Ther (2015) 0.82
Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE. J Biol Chem (2015) 0.82
Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion. Biomed Res Int (2013) 0.81
Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia. Schizophr Res (2014) 0.81
Histological assessment of cerebellar granule cell layer in postmortem brain; a useful marker of tissue integrity? Cell Tissue Bank (2011) 0.80
Neurotrophin receptors expression in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with seizure type and surgical outcome. Acta Neuropathol Commun (2014) 0.80
Transcriptional correlates of human substance use. Ann N Y Acad Sci (2008) 0.80
Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophr Res (2015) 0.79
Human brain weight is correlated with expression of the 'housekeeping genes' beta-2-microglobulin (β2M) and TATA-binding protein (TBP). Neuropathol Appl Neurobiol (2010) 0.79
The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimers Res Ther (2015) 0.79
Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia. BMC Psychiatry (2016) 0.78
Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression. BMC Cancer (2015) 0.78
Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study. BMC Psychiatry (2012) 0.78
Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain. Transl Psychiatry (2015) 0.78
Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profile. Proteomics (2016) 0.78
ΔFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes. Neuropsychopharmacology (2013) 0.77
NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases. Database (Oxford) (2015) 0.77
Investigating the potential influence of cause of death and cocaine levels on the differential expression of genes associated with cocaine abuse. PLoS One (2015) 0.77
Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence. PLoS One (2015) 0.77
Identification of long noncoding RNAs dysregulated in the midbrain of human cocaine abusers. J Neurochem (2015) 0.77
Mesial temporal lobe epilepsy with psychiatric comorbidities: a place for differential neuroinflammatory interplay. J Neuroinflammation (2015) 0.77
Gene expression profiling in the human alcoholic brain. Neuropharmacology (2017) 0.76
Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia. Schizophr Res (2014) 0.76
Deep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson's disease. Mol Neurodegener (2016) 0.76
Alcoholics have more tryptophan hydroxylase 2 mRNA and protein in the dorsal and median raphe nuclei. Alcohol Clin Exp Res (2014) 0.76
Limited predictability of postmortem human brain tissue quality by RNA integrity numbers. J Neurochem (2016) 0.76
Global and Site-Specific Changes in 5-Methylcytosine and 5-Hydroxymethylcytosine after Extended Post-mortem Interval. Front Genet (2016) 0.76
COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia. Schizophr Res (2016) 0.75
An International Survey of Brain Banking Operation and Characterization Practices. Biopreserv Biobank (2016) 0.75
Factors That Influence the Quality of RNA From the Pancreas of Organ Donors. Pancreas (2016) 0.75
Human postmortem lacrimal and submandibular glands stored in RNAlater are suitable for molecular, biochemical, and cell biological studies. Mol Vis (2016) 0.75
Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra. Neuropsychopharmacology (2016) 0.75
Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study. Schizophr Res (2016) 0.75
Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res (2005) 7.63
Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques (2004) 4.48
The stanley foundation brain collection and neuropathology consortium. Schizophr Res (2000) 3.37
Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res (2002) 3.15
The role of mRNA and protein stability in gene expression. FASEB J (1989) 2.64
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett (1995) 2.35
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci (2001) 1.98
Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res (1995) 1.98
The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology (2002) 1.94
Biochemical and molecular studies using human autopsy brain tissue. J Neurochem (2003) 1.60
Extensive postmortem stability of RNA from rat and human brain. J Neurosci Res (1986) 1.58
Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J (2005) 1.55
Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res (2003) 1.44
Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods (1997) 1.44
Pre- and postmortem influences on brain RNA. J Neurochem (1993) 1.41
Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat (2001) 1.36
Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials. Prog Brain Res (1992) 1.26
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. BMC Bioinformatics (2006) 1.24
Reliability of psychiatric diagnosis in postmortem research. Biol Psychiatry (2005) 1.24
High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res (2000) 1.22
TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem Int (2006) 1.15
Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry (1993) 1.14
DNA chip technology in brain banks: confronting a degrading world. J Neuropathol Exp Neurol (2004) 1.08
Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay. J Neurosci Methods (2004) 1.04
Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. Neurochem Pathol (1985) 1.03
Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Brain Res Mol Brain Res (1991) 1.03
An optimistic view for quantifying mRNA in post-mortem human brain. Brain Res Mol Brain Res (2003) 0.93
On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease. J Neurochem (1992) 0.92
Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacology (2003) 0.91
Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain. Neurobiol Aging (1996) 0.91
The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortex. J Neurochem (1994) 0.90
Stability of gene expression in postmortem brain revealed by cDNA gene array analysis. Brain Res (2002) 0.90
Synaptophysin immunoreactivity is stable 36 h postmortem. Dementia (1995) 0.84
The effect of postmortem delay on the distribution of microtubule-associated proteins tau, MAP2, and MAP5 in the rat. Mol Chem Neuropathol (1997) 0.83
The neuropathology of schizophrenia: a critical assessment of research methodologies. Biol Psychiatry (1990) 0.82
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell (2007) 8.99
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol (2008) 5.58
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol (2007) 5.02
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci (2010) 3.47
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med (2012) 3.30
Antidepressant actions of histone deacetylase inhibitors. J Neurosci (2009) 3.17
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab (2012) 2.86
Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci (2010) 2.84
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry (2003) 2.82
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
Conflict of interest. Am J Psychiatry (2006) 2.30
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol Psychiatry (2009) 2.25
Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One (2008) 2.22
Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am J Psychiatry (2008) 2.13
Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med (2010) 2.09
Metabolism of [U-13 C]glucose in human brain tumors in vivo. NMR Biomed (2012) 2.06
The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth. Clin Cancer Res (2010) 1.96
A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron (2011) 1.92
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol (2014) 1.90
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry (2013) 1.85
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res (2009) 1.79
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.76
Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res (2006) 1.72
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology (2013) 1.70
Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med (2013) 1.70
Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. Am J Psychiatry (2012) 1.61
A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci (2011) 1.61
Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet (2011) 1.60
AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry (2008) 1.60
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology (2006) 1.53
Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biol Psychiatry (2009) 1.47
In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proc Natl Acad Sci U S A (2014) 1.44
Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia. Synapse (2011) 1.43
Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.43
DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol (2006) 1.42
Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry (2015) 1.40
On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI. NMR Biomed (2009) 1.36
Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry (2013) 1.35
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging (2012) 1.30
Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Hum Mutat (2008) 1.30
Baseline blood oxygenation modulates response amplitude: Physiologic basis for intersubject variations in functional MRI signals. Magn Reson Med (2008) 1.27
Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J Neurosci (2008) 1.27
Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary. Neurosci Biobehav Rev (2009) 1.26
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors. NMR Biomed (2012) 1.23
The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res (2009) 1.22
Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatry (2011) 1.22
Reimagining psychoses: an agnostic approach to diagnosis. Schizophr Res (2013) 1.20
Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull (2010) 1.19
Serum response factor promotes resilience to chronic social stress through the induction of DeltaFosB. J Neurosci (2010) 1.19
TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol (2010) 1.19
Insight and frontal cortical function in schizophrenia: a review. Schizophr Res (2006) 1.18
Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry (2002) 1.17
Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry (2005) 1.17
Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis (2011) 1.16
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res (2011) 1.16
Regional alterations in RGS4 protein in schizophrenia. Synapse (2006) 1.15
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem (2010) 1.14
Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol (2008) 1.12
Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry (2003) 1.11
The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study. J Clin Psychopharmacol (2003) 1.10
Long-term psychiatric outcomes following traumatic brain injury: a review of the literature. J Head Trauma Rehabil (2009) 1.10
Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis (2003) 1.09
Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology (2005) 1.08
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res (2009) 1.08
Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry (2003) 1.07
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.07
Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol Dis (2007) 1.06
Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology (2009) 1.06
Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol (2005) 1.04
Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr Bull (2008) 1.03
[(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry (2002) 1.03
Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biol Psychiatry (2012) 1.02
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol (2011) 1.01
Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J Neurosci (2008) 1.01
Regional expression of RGS4 mRNA in human brain. Eur J Neurosci (2004) 1.01
Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophr Bull (2012) 1.01